Global Next Generation Sequencing Market Is Poised to Grow at a Cagr of More Than 20 Percent to Reach Around $5.0 Billion by 2020

Submitted by: Submitted by

Views: 50

Words: 963

Pages: 4

Category: Business and Industry

Date Submitted: 11/30/2014 11:21 PM

Report This Essay

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

"Next generation Sequencing (NGS) has revolutionized the way the human genomes are being sequenced now a days. The time and cost to sequence has tremendously reduced since the first human genome was sequenced, which took a decade time and around $3 billion.

To Browse a Full Report with Toc: http://www.researchmoz.us/global-next-generation-sequencing-technologies-market-analysis-trends-and-forecast-to-2020-report.html

According to experts, in the coming years, a human genome can be sequenced at a cost of $1,000 in one to two days. In the last five years the sequencing cost has rapidly reduced and this is supposed to have a huge impact on the NGS market in the coming years. Until recently, uses of Next Generation Sequencing tools were limited to research Nowadays, NGS technologies have found applications mainly in two fields clinical diagnostics and infectious diseases. This report describes both current and future applications of NGS.

The global Next Generation Sequencing market is poised to grow at a CAGR of more than 20% to reach around $5.0 billion by 2020. The NGS market assessment was made based on products, technologies, end users, applications and geography. The NGS products market is further divided into instruments and reagents, services and workflow products. The instruments and consumables is the largest segment with a share of around half of the market in 2013. The fastest growing segment is the services with a highest CAGR during the forecast period. The major players are interested in services segment as it provides additional revenue for the company at the same time, increases the sales of instruments and reagents.

NGS technology is segmented into targeted resequencing, whole exome sequencing, RNA sequencing, whole genome sequencing, ChIP sequencing, de novo sequencing and methyl sequencing....